In this opinion, the EESC fully supports the priorities identified by the Commission and reiterates the need for a cohesive European response. The EESC also stresses that removing barriers is key and that regulatory simplification must take place with full respect for social and workers’ rights. Finally, it calls on the Commission to put forward legislative proposals to address regional supply constraints.
This exploratory opinion, requested by the Danish Presidency, outlines how AI and Big Data can improve rare disease patient pathways and support the development of personalised treatments. It highlights the main challenges linked to their use, such as data privacy, algorithmic bias, affordability, and geographical accessibility. In the text, the EESC puts forward recommendations to ensure that these technologies are applied in an ethical, inclusive, and patient-centred way.
Download — Avizul CESE: AI, Big Data and rare diseases
Clean technologies are projected to continue expanding in turnover, investments and jobs. Thanks to ambitious climate targets, the EU is a global leader in high-value inventions and was an early mover in developing a cleantech production base. However, it has lost technological leadership in several sectors and its manufacturing base is eroding.
Download — Avizul CESE: Building blocks for strengthening Europe’s manufacturing base in cleantech
